Naphthyridine derivatives and their use as modulators of muscarinic receptors

Details for Australian Patent Application No. 2004297241 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Makings, Lewis R.; Grootenhuis, Peter D. J.; Londo, Philip Martin; GarciaGuzman Blanco, Miguel

Agent Spruson & Ferguson

Pub. Number AU-A-2004297241

PCT Pub. Number WO2005/056552

Priority 60/528,049 09.12.03 US

Filing date 7 December 2004

Wipo publication date 23 June 2005

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/056552 Priority application(s): WO2005/056552

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004297243-Oxazole derivatives of tetracyclines

2004297237-Conveyor belt assembly